T. Rowe Price (TROW) Q2 2026 Earnings Call Transcript

T. Rowe Price reported Q2 2026 adjusted diluted EPS of $2.57 (vs. $2.52 in Q1 and $2.24 in Q2’25) on adjusted net revenue of $1.9B (+8.5% YoY), but net outflows totaled $6.5B in the quarter (equity outflows of $13.5B partially offset by inflows in fixed income, multi-asset and alternatives). Effective fee rate fell to 38.1 bps (from 38.4 bps in Q1) due to a shift toward lower-fee vehicles, while adjusted operating expenses were $1.2B (+4.9% YoY). The firm guided full-year 2026 adjusted operating expenses (excluding carried interest) to grow 4%-7% and noted H2 flows are expected to be “meaningfully more challenging” given ongoing active equity outflows.

Analysis

The market should treat this as a mixed-quality print: headline AUM is leverage, but most of that is beta, not evidence that the core franchise is re-accelerating. The key mechanism is mix: the business is getting pulled toward lower-fee wrappers and categories, so even if revenue rises with markets, the long-run earnings power depends on whether ETF/SMA and advice-led channels can offset structurally weaker economics in legacy equity mandates. That makes the stock more of a flow and product-mix story than a simple earnings beat.

Second-order, the real winners are firms with stronger distribution into model portfolios, wealth, and alternatives — especially GS and MS on the wallet/advice side, and potentially JPM in retirement and multi-asset channels. TROW’s strength in fixed income and lower-tracking-error active products helps defend share, but it does not fully solve the problem that the largest pool of assets still sits in areas with persistent outflows. The implication is that competitors with broader platform economics can use TROW’s transition period to take shelf space before the new products scale.

Catalyst risk is front-loaded into the next 1-3 months: flows likely worsen as post-rally equity rebalancing, a weaker target-date pipeline, and ongoing mutual fund redemptions hit the numbers. Over 6-18 months, the upside case depends on whether ETFs, SMAs, and the Goldman alternative platform become material enough to change the revenue mix; without that, buybacks mainly mask, rather than fix, the organic growth problem. The contrarian view is that consensus may be too focused on near-term outflows and too dismissive of the firm’s option value in retirement, model delivery, and tokenized distribution — but that option is still too small to justify paying up aggressively today.

What would falsify the bullish transition thesis is a sustained failure of ETF/SMA net inflows to offset equity mutual fund redemptions by year-end, or another step-down in the effective fee rate without a corresponding expense reset. If that happens, the stock likely reverts to a low-growth asset manager multiple rather than a platform-transformation multiple.

Key Decisions for Investors

• Hold TROW only as a low-conviction, cash-yielding transition story for 1-3 months; do not chase strength until ETF/SMA net inflows visibly offset equity mutual fund outflows in the next two quarters.
• Pair trade: long GS / short TROW for the next 3-6 months if you want exposure to the same private-markets/wealth theme with better operating leverage and deeper distribution economics.
• Relative-value long TROW vs. a broad asset-manager basket if the stock sells off on flow headlines; the downside is already well-telegraphed, while buybacks and balance-sheet liquidity limit near-term drawdown risk.
• Use a stop-loss/watch level around any sustained deterioration in effective fee rate or a renewed sequential acceleration in equity outflows; if either happens, the mix story is failing faster than expected.